Can I Use Dermoplast While Pregnant?

No, clinical evidence on Dermoplast (benzocaine spray) during pregnancy is limited, and the manufacturer recommends consulting a doctor before use.

Packing a hospital bag for delivery means making a lot of decisions. One common item on many lists is a numbing spray for postpartum perineal soreness. Dermoplast, with its benzocaine formula and soothing aloe, shows up in birth center recommendations and mom forums. That creates a natural question for anyone still pregnant — can you use it before delivery?

Here’s the honest answer: there is no large-scale pregnancy study confirming Dermoplast is safe or unsafe. Drug references like Drugs.com advise asking a doctor before use, and the manufacturer says the same. Clinical guidance from Healio notes no known evidence of developmental toxicity with topical benzocaine but still recommends a risk-benefit assessment. The bottom line is you need a conversation with your obstetrician.

What Dermoplast Is and How It Works

Dermoplast is a topical spray sold over the counter. The postpartum formulation contains 20% benzocaine as the active numbing agent, along with aloe and lanolin for soothing. It’s classified as a topical anesthetic, applied directly to the skin to relieve pain, burning, and discomfort from minor irritations and postpartum perineal trauma.

Benzocaine works by blocking nerve signals in the area where it’s sprayed. The drug temporarily stops pain signals from reaching the brain through local numbing. That effect is what makes it useful for episiotomy stitches, vaginal tears, and hemorrhoid discomfort after birth.

The product label instructs users to clean the affected area with mild soap and warm water before applying the spray. It’s designed for external use only, and the postpartum formulation is specifically marketed for perineal pain after vaginal delivery.

Why the “Is It Safe” Question Is Tricky

Pregnancy drug research is ethically complicated. Drug companies rarely test new products on pregnant people for fear of liability, so most medications carry limited pregnancy data. That leaves patients and doctors weighing theoretical risk against real need. Dermoplast sits squarely in that gray area.

• No large-scale trials exist: No controlled studies have tested Dermoplast specifically during pregnancy. The evidence comes from expert opinion and general knowledge about topical benzocaine.
• Systemic absorption is low: Topical application to intact skin leads to minimal absorption into the bloodstream. The concern would be higher with broken skin or very large application areas.
• Manufacturer and drug references agree: Both Dermoplast’s FAQ and Drugs.com direct pregnant users to consult a doctor rather than offering a blanket safety statement.
• Clinical guidance is reassuring but cautious: Healio’s expert review states there is no known evidence of developmental toxicity with topical anesthetics, but still advises a risk-benefit evaluation.

The pattern is consistent across sources: nobody says “don’t use it,” and nobody says “definitely safe.” That kind of uncertainty can feel unsatisfying, but it reflects the thoughtful caution pregnancy care requires. Your obstetrician can help weigh your specific situation.

What the Research Actually Says

The strongest clinical reference comes from Healio, which cites the Briggs pregnancy risk assessment for topical anesthetics. Their conclusion: no known evidence of developmental toxicity exists for topical agents like benzocaine. That’s the closest thing to a clear signal in the available data.

The mechanism is straightforward — benzocaine works locally by blocking sodium channels in nerve membranes, which stops pain signals from traveling to the brain. The NLM’s DailyMed label explains the process in detail — see the benzocaine numbing mechanism entry for the full description. Because very little of the drug enters the bloodstream when applied to intact skin, the theoretical risk to a fetus is low.

That said, “low theoretical risk” is not the same as “proven safe in pregnancy.” The FDA label does not include pregnancy-specific dosing guidance. Epocrates offers professional-level information for clinicians, which suggests doctors regularly encounter this product — but always with individual assessment.

Across these sources, the message is consistent: topical benzocaine has a favorable safety profile based on what is known, but the absence of pregnancy-specific trials means providers must make individual calls. That’s standard for many OTC products used during pregnancy.

How to Approach Dermoplast Before Delivery

If you’re pregnant and considering Dermoplast for a current issue — hemorrhoids, a skin irritation, or general perineal discomfort — here’s a reasonable approach based on available guidance.

1. Start with your OB or midwife: Share what you’re treating and ask if Dermoplast is appropriate for your stage of pregnancy and any risk factors.
2. Consider timing and trimester: Most medication concern centers on the first trimester, when fetal organs are developing. Third-trimester use for postpartum planning is a separate conversation.
3. Check the specific formulation: Dermoplast comes in different versions. The postpartum spray contains 20% benzocaine. Make sure you’re discussing the exact product you plan to use.
4. Use as directed if cleared: Apply only to the affected area, cleanse the skin first, and avoid use on large open wounds per the DailyMed label instructions.

Many clinicians are comfortable with topical anesthetics for localized use during pregnancy, especially later in the third trimester. But that comfort level varies by provider and patient history. The safest answer is the one your specific doctor gives you.

What About After Birth?

Postpartum Use Has More Support

The more common use for Dermoplast is after delivery, for perineal pain from stitches, tears, or general soreness. In that context, the spray is widely recommended. El Camino Women’s health center lists it as a recommended product, and various postpartum guides suggest it for managing pain from perineal stitches.

The broader research on pain medication during pregnancy and postpartum offers useful context. A peer-reviewed article in PMC notes that commonly prescribed pain medications appear relatively safe, with none found to increase the risk of major malformations. The pain medications pregnancy safety review does caution about use in late pregnancy and during breastfeeding — another reason to check with your provider.

For postpartum use specifically, Dermoplast is applied topically to the perineum after cleansing. The numbing effect from benzocaine lasts for a limited time, and the product can be reapplied according to package directions. Most users find it provides temporary relief during the most sensitive first days of healing.

The Bottom Line

Dermoplast is likely low-risk for most pregnant people when used topically and as directed, but no large studies confirm that. The clinical guidance suggests no known developmental toxicity from topical anesthetics, yet both the manufacturer and independent drug references advise consulting a doctor first. That’s the honest middle ground.

Your obstetrician or midwife can assess your specific needs and trimester before clearing you to pack that postpartum spray in your hospital bag.